BASEL, Switzerland – October 31, 2022 — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, will be hosting an enlightening panel discussion, “Hope or Hype?: The importance of Multimodal Data Integration to Advance Precision Medicine” at the BioData World Congress. The panel discussion and congress will take place with physical attendance, in Basel, Switzerland on November 9, 2022 at 12:05 p.m. CET at the Congress Center Basel.
Peter Casasanto, Chief BioPharma Officer at SOPHiA GENETICS, will moderate industry experts including:
- Dr. Philippe Menu, Chief Medical Officer, SOPHiA GENETICS
- David Dellamonica, Head, Digital and Innovation, Oncology Europe & Canada, AstraZeneca
- Michael Frank, Digital Ventures Lead, Memorial Sloan Kettering Cancer Center
- Prof. Jacques Cadranel, Professor of Pneumology at Sorbonne Université and Head of the Department of Pneumology and Thoracic Oncology at the Tenon APHP-SU Hospital.
These esteemed panelists will discuss topics such as the importance of multimodal data integration to advance precision medicine, the role of A.I. and real-world data in clinical practice, how we can scale the use of A.I. in clinical practice, and what the main challenges are to apply A.I. in healthcare.
The BioData World Congress is Europe’s largest congress covering big data in pharmaceutical development and healthcare. Interested parties can register for the conference here.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn, Facebook, and Instagram. Where others see data, we see answers.
###
Media Contact:
Kelly Katapodis
Senior Manager, Media & Communications
[email protected]
